In the last decade, in vitro research has been performed to develop SOCS mimetics and SOCS antagonists, which have shown encouraging results in mouse models of autoimmune-associated diseases like diabetes and multiple sclerosis. This evidence concerns the gene CISH and multiple sclerosis.